No products in the cart.
Cat:GMP-h-CA50
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Genemedi produces core diagnostic ingredients for test of Cancer (pancreatic and colorectal
cancer) and related syndrome. GeneMedi offers paired diagnostics grade Carbohydrate Antigen 50 (CA50) antibodies (monoclonal antibody, mab) and antigens for Cancer (pancreatic and colorectal
cancer) rapid test kit of Carbohydrate Antigen 50 (CA50) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Cancer (pancreatic and colorectal
cancer ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Cancer-associated carbohydrate antigen 50
(CA50) is a ganglioside glycoprotein and is a biomarker for the diagnosis and
prognosis of gastrointestinal malignancies, especially of pancreatic and
colorectal cancers. The expression level of CA50 has been measured for
pancreatic and colorectal cancers and also for other cancers such as breast,
lung, renal, prostatic, and ovarian cancers. In addition, it can distinguish
the patients of benign disease of atrophic gastritis, pancreatitis, ulcerative
colitis, pneumonia, cirrhosis, and autoimmune diseases from healthy persons.
Product Description
Cat No. of Pruducts
GMP-h-CA50-Ag01:Recombinant Human CA50 Protein
Product Name
Recombinant Human CA50 Protein
Target
Carbohydrate Antigen 50
Alias of Target/Biomarker
#N/A
Expression platform
E.coli
Isotypes
Recombinant Antigen
Bioactivity validation
Carbohydrate Antigen 50 (CA50) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA50 level test of Cancer (pancreatic and colorectal
cancer) and related syndrome evaluation
Tag
His
Products description
Recombinant Human CA50 Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Previous slide
Next slide
Cat No. of Pruducts
GMP-h-CA50-Ab01,GMP-h-CA50-Ab02:Anti-Human CA50 mouse monoclonal antibody (mAb)
Product Name
Anti-Human CA50 mouse monoclonal antibody (mAb)
Target
Alias of Target/Biomarker
#N/A
Expression platform
Hybridoma
Isotypes
Mouse IgG
Bioactivity validation
Human Carbohydrate Antigen 50 (CA50) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Carbohydrate Antigen 50 (CA50) antibodies in CA50 level test of Cancer (pancreatic and colorectal
cancer) and related syndrome evaluation.
Tag
mFc
Products description
Anti-Human CA50 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Carbohydrate Antigen 50 (CA50) antibodies.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1
Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
